Oramed Pharmaceuticals
ORMP
#8980
Rank
NZ$0.22 B
Marketcap
NZ$5.58
Share price
0.30%
Change (1 day)
45.01%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): NZ$1.44

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.33. In 2024 the company made an earnings per share (EPS) of NZ-$0.79 a decrease over its 2023 EPS that were of NZ$0.23.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.44-281.5%
2024NZ-$0.79-442.86%
2023NZ$0.23-114.89%
2022NZ-$1.5520.51%
2021NZ-$1.2839.29%
2020NZ-$0.92-31.71%
2019NZ-$1.35-4.65%
2018NZ-$1.428.86%
2017NZ-$1.30-9.2%
2016NZ-$1.4329.85%
2015NZ-$1.108.06%
2014NZ-$1.025.08%
2013NZ-$0.973.51%
2012NZ-$0.94137.5%
2011NZ-$0.40-60%
2010NZ-$0.99-0%
2009NZ-$0.99-16.67%
2008NZ-$1.19-25%
2007NZ-$1.58700%
2006NZ-$0.20303.56%
2005NZ-$0.04898

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
NZ$5.79 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$3.40 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ-$9.78-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ-$0.31-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ-$0.49-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel